Clinical Trials Browser

Terminated × INDUSTRY × galiximab × Clear all

NCT00384150 2015-11-26

Retreatment Study of Galiximab + Rituximab in Follicular Non-Hodgkin's Lymphoma (NHL)

Phase 3 Terminated

Lymphoma, Non-Hodgkin, Recurrence

NCT00363636 2015-10-02

A Study of Galiximab + Rituximab Versus Rituximab + Placebo in Follicular Non-Hodgkin's Lymphoma (NHL)

Phase 3 Terminated

Lymphoma, Non-Hodgkin, Recurrence

NCT00651443 2011-01-07

Mechanism of Action of Galiximab in Subjects With Previously Untreated Follicular Non-Hodgkin's Lymphoma

Phase 1 Terminated

Lymphoma, Non-Hodgkin